TY - JOUR T1 - CVA-Flow novel telestroke system preliminary trial: reliability in determining NIHSS for acute ischemic stroke JF - medRxiv DO - 10.1101/2021.04.07.21254957 SP - 2021.04.07.21254957 AU - Saban Mor AU - Moskovitz Anner AU - Ohanian Sona AU - Reznik Anna AU - Ribo Marc AU - Sivan-Hoffmann Rotem Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/10/2021.04.07.21254957.abstract N2 - Background The National Institutes of Health Stroke Scale (NIHSS) is the most recommended tool for objectively quantifying the impairment caused by a suspected stroke. Nevertheless, it is used almost solely by trained neurologists in the emergency departments (ED) setting. CVA-Flow (CVAid medical Ltd., Tel-Aviv, Israel) is a smartphone-based Telestroke system that captures the full NIHSS by video and enables a distant stroke physician to assess the patient’s neurological status, bringing forward the NIHSS to the pre-hospital setting.Objective We aimed to compare the reliability of an NIHSS score determined by a neurologist from afar, using the CVA-Flow platform, with a standard NIHSS assessment performed in the ED).Methods In this multi-center prospective trial, Patients admitted to the ED in Rambam hospital in Haifa, Israel, and Vall d’Hebron hospital (VdH) in Barcelona, Spain, had a neurological exam based on the NIHSS while being recorded by the system. A neurologist blinded to the results rated the NIHSS according to the videos offline.Results A total of 95 patients with a suspected stroke were included. Overall ICC was 0.936 (0.99 in VdH and 0.84 in Rambam), indicating excellent and good reliability, respectively.Conclusion Remote stroke assessment based on the NIHSS, using videos collected by the CVA-Flow platform, installed on a standard smartphone, is a reliable measurement as compared with bedside evaluation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the Institutional Human Subjects Ethics Committee of Rambam health care campus and Vall d'Hebron hospital (IRB-0187-18). All procedures performed were in accordance with the ethical standards of the institutional and national research committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article ER -